Interim Efficacy Analysis of Different Anticoagulation Regimens in Patients with Long-Term Implantation of Inferior Vena Cava Filter
Seminars in Thrombosis and Hemostasis · 20.08.2026
DOI: 10.1055/a-2930-7434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 20.08.2026. Verfasst von Lei Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, People's Republic of China, Shanghai. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Project of Integration Team of Tengfei Engineering of The Third Affiliated Hospital of Naval Medical University.
Abstract (Originalsprache)
This study aimed to analyze the interim efficacy of different anticoagulation regimens for patients with long-term inferior vena cava filter (IVCF) implantation. From August 2021 to August 2024, a retrospective analysis of patients who underwent long-term IVCF implantation in multiple centers was performed. Group A (46 cases) did not receive anticoagulation, Group B (66 cases) received extended secondary prophylaxis dose anticoagulation, and Group C (63 cases) received extended therapeutic dose anticoagulation, with 12 months follow-up. The primary endpoint was lower extremity deep vein thrombosis (LEDVT) recurrence rate. The secondary endpoints were IVCF thrombosis (IVCFT) incidence, bleeding-related adverse events incidence, all-cause mortality, and venous clinical severity score (VCSS). LEDVT recurrence rate and IVCFT incidence in Group A (37.0 and 19.6%) were higher than that in Group B (13.6 and 6.1%) and Group C (15.9 and 4.8%). Bleeding-related adverse events incidence in Group C (17.5%) was higher than that in Group B (4.5%) and Group A (2.2%). There was no significant difference in all-cause mortality among the three groups. VCSS at 12 months in Group A was higher than that in Group B and Group C. In the interim follow-up of the extended treatment phase in patients with long-term IVCF implantation and rivaroxaban anticoagulation may reduce LEDVT recurrence and IVCFT occurrence compared with non-anticoagulation, and alleviate patients' clinical symptoms. The extended secondary prophylaxis dose may exhibit comparable efficacy to the extended therapeutic dose, while potentially reducing the bleeding risk.
Autor:innen und Institutionen
- Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, People's Republic of China, Shanghai.
- The Third People's Hospital of Hefei (Hefei Third Clinical College of Anhui Medical University), Department of Interventional Vascular, Anhui, People's Republic of China, Hefei.
- The Fourth Affiliated Hospital of Soochow University, Department of Vascular Surgery and Intervention, People's Republic of China, Suzhou.
- The Third Affiliated Hospital of Naval Medical University, Department of Vascular Surgery, People's Republic of China, Shanghai.
- The First Affiliated Hospital of Anhui University of Chinese Medicine, Department of Vascular Surgery, People's Republic of China, Hefei.
ORCID-Profile: Lei Qi, Hongzhi Sun, Yihao Wang, Huagang Li, Shuangshuang Li, Jian Zhou
Förderung
- The National Natural Science Foundation of China
- The Project of Integration Team of Tengfei Engineering of The Third Affiliated Hospital of Naval Medical University
Zitieren
APA
Qi, L., Sun, H., Wang, Y., Li, H., Li, S., & Zhou, J. (2026). Interim Efficacy Analysis of Different Anticoagulation Regimens in Patients with Long-Term Implantation of Inferior Vena Cava Filter. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2930-7434
Vancouver
Qi L, Sun H, Wang Y, Li H, Li S, Zhou J. Interim Efficacy Analysis of Different Anticoagulation Regimens in Patients with Long-Term Implantation of Inferior Vena Cava Filter. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2930-7434
BibTeX
@article{Qi2026,
author = {Qi, Lei and Sun, Hongzhi and Wang, Yihao and Li, Huagang and Li, Shuangshuang and Zhou, Jian},
title = {Interim Efficacy Analysis of Different Anticoagulation Regimens in Patients with Long-Term Implantation of Inferior Vena Cava Filter},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
doi = {10.1055/a-2930-7434}
}
EUVIMED